 | • レポートコード：B-GIR08C1936 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：Chemical & Material |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、エクリズマブの世界市場について調べ、まとめました。種類別セグメントは、プラズマ交換、プラズマ注入等、用途別セグメントは、PNH H aHUS、その他等に区分しました。エクリズマブの世界市場概観、企業動向、企業別エクリズマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・エクリズマブの市場概観 ・エクリズマブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・エクリズマブの企業別販売動向、市場シェア、市場集中度、競争動向 ・エクリズマブの世界市場規模 ・エクリズマブの北米市場分析（アメリカ、カナダ、メキシコ等） ・エクリズマブのアメリカ市場規模推移 ・エクリズマブのカナダ市場規模推移 ・エクリズマブのメキシコ市場規模推移 ・エクリズマブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・エクリズマブのドイツ市場規模推移 ・エクリズマブのイギリス市場規模推移 ・エクリズマブのロシア市場規模推移 ・エクリズマブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・エクリズマブの日本市場規模推移 ・エクリズマブの中国市場規模推移 ・エクリズマブの韓国市場規模推移 ・エクリズマブのインド市場規模推移 ・エクリズマブの東南アジア市場規模推移 ・エクリズマブの南米市場分析（ブラジル、アルゼンチン等） ・エクリズマブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・エクリズマブの種類別分析/販売量、売上、市場シェア（プラズマ交換、プラズマ注入） ・エクリズマブの用途別分析/市場規模（PNH H aHUS、その他） ・エクリズマブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・エクリズマブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Eculizumab is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Eculizumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Alexion
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Plasma Exchange
Plasma Infusion
Market Segment by Applications, can be divided into
PNH
aHUS
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eculizumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Eculizumab, with price, sales, revenue and global market share of Eculizumab in 2017 and 2018.
Chapter 3, the Eculizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eculizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Eculizumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Eculizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Eculizumab Introduction
1.2 Market Analysis by Type
1.2.1 Plasma Exchange
1.2.2 Plasma Infusion
1.3 Market Analysis by Applications
1.3.1 PNH
1.3.2 aHUS
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alexion
2.1.1 Business Overview
2.1.2 Eculizumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alexion Eculizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Eculizumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Eculizumab Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Eculizumab Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Eculizumab Manufacturer Market Share in 2018
3.3.2 Top 6 Eculizumab Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Eculizumab Market Analysis by Regions
4.1 Global Eculizumab Sales, Revenue and Market Share by Regions
4.1.1 Global Eculizumab Sales and Market Share by Regions (2014-2019)
4.1.2 Global Eculizumab Revenue and Market Share by Regions (2014-2019)
4.2 North America Eculizumab Sales and Growth Rate (2014-2019)
4.3 Europe Eculizumab Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Eculizumab Sales and Growth Rate (2014-2019)
4.5 South America Eculizumab Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Eculizumab Sales and Growth Rate (2014-2019)
5 North America Eculizumab by Country
5.1 North America Eculizumab Sales, Revenue and Market Share by Country
5.1.1 North America Eculizumab Sales and Market Share by Country (2014-2019)
5.1.2 North America Eculizumab Revenue and Market Share by Country (2014-2019)
5.2 United States Eculizumab Sales and Growth Rate (2014-2019)
5.3 Canada Eculizumab Sales and Growth Rate (2014-2019)
5.4 Mexico Eculizumab Sales and Growth Rate (2014-2019)
6 Europe Eculizumab by Country
6.1 Europe Eculizumab Sales, Revenue and Market Share by Country
6.1.1 Europe Eculizumab Sales and Market Share by Country (2014-2019)
6.1.2 Europe Eculizumab Revenue and Market Share by Country (2014-2019)
6.2 Germany Eculizumab Sales and Growth Rate (2014-2019)
6.3 UK Eculizumab Sales and Growth Rate (2014-2019)
6.4 France Eculizumab Sales and Growth Rate (2014-2019)
6.5 Russia Eculizumab Sales and Growth Rate (2014-2019)
6.6 Italy Eculizumab Sales and Growth Rate (2014-2019)
7 Asia-Pacific Eculizumab by Country
7.1 Asia-Pacific Eculizumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Eculizumab Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Eculizumab Revenue and Market Share by Country (2014-2019)
7.2 China Eculizumab Sales and Growth Rate (2014-2019)
7.3 Japan Eculizumab Sales and Growth Rate (2014-2019)
7.4 Korea Eculizumab Sales and Growth Rate (2014-2019)
7.5 India Eculizumab Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Eculizumab Sales and Growth Rate (2014-2019)
8 South America Eculizumab by Country
8.1 South America Eculizumab Sales, Revenue and Market Share by Country
8.1.1 South America Eculizumab Sales and Market Share by Country (2014-2019)
8.1.2 South America Eculizumab Revenue and Market Share by Country (2014-2019)
8.2 Brazil Eculizumab Sales and Growth Rate (2014-2019)
8.3 Argentina Eculizumab Sales and Growth Rate (2014-2019)
8.4 Colombia Eculizumab Sales and Growth Rate (2014-2019)
9 Middle East and Africa Eculizumab by Countries
9.1 Middle East and Africa Eculizumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Eculizumab Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Eculizumab Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Eculizumab Sales and Growth Rate (2014-2019)
9.3 Turkey Eculizumab Sales and Growth Rate (2014-2019)
9.4 Egypt Eculizumab Sales and Growth Rate (2014-2019)
9.5 Nigeria Eculizumab Sales and Growth Rate (2014-2019)
9.6 South Africa Eculizumab Sales and Growth Rate (2014-2019)
10 Global Eculizumab Market Segment by Type
10.1 Global Eculizumab Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Eculizumab Sales and Market Share by Type (2014-2019)
10.1.2 Global Eculizumab Revenue and Market Share by Type (2014-2019)
10.2 Plasma Exchange Sales Growth and Price
10.2.1 Global Plasma Exchange Sales Growth (2014-2019)
10.2.2 Global Plasma Exchange Price (2014-2019)
10.3 Plasma Infusion Sales Growth and Price
10.3.1 Global Plasma Infusion Sales Growth (2014-2019)
10.3.2 Global Plasma Infusion Price (2014-2019)
11 Global Eculizumab Market Segment by Application
11.1 Global Eculizumab Sales Market Share by Application (2014-2019)
11.2 PNH Sales Growth (2014-2019)
11.3 aHUS Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Eculizumab Market Forecast (2019-2024)
12.1 Global Eculizumab Sales, Revenue and Growth Rate (2019-2024)
12.2 Eculizumab Market Forecast by Regions (2019-2024)
12.2.1 North America Eculizumab Market Forecast (2019-2024)
12.2.2 Europe Eculizumab Market Forecast (2019-2024)
12.2.3 Asia-Pacific Eculizumab Market Forecast (2019-2024)
12.2.4 South America Eculizumab Market Forecast (2019-2024)
12.2.5 Middle East and Africa Eculizumab Market Forecast (2019-2024)
12.3 Eculizumab Market Forecast by Type (2019-2024)
12.3.1 Global Eculizumab Sales Forecast by Type (2019-2024)
12.3.2 Global Eculizumab Market Share Forecast by Type (2019-2024)
12.4 Eculizumab Market Forecast by Application (2019-2024)
12.4.1 Global Eculizumab Sales Forecast by Application (2019-2024)
12.4.2 Global Eculizumab Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Eculizumab Picture
Table Product Specifications of Eculizumab
Figure Global Sales Market Share of Eculizumab by Types in 2018
Table Eculizumab Types for Major Manufacturers
Figure Plasma Exchange Picture
Figure Plasma Infusion Picture
Figure Eculizumab Sales Market Share by Applications in 2018
Figure PNH Picture
Figure aHUS Picture
Figure Other Picture
Figure United States Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure France Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure UK Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure China Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure India Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Eculizumab Revenue (Value) and Growth Rate (2014-2024)
Table Alexion Basic Information, Manufacturing Base and Competitors
Table Alexion Eculizumab Type and Applications
Table Alexion Eculizumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Eculizumab Sales by Manufacturer (2017-2018)
Figure Global Eculizumab Sales Market Share by Manufacturer in 2017
Figure Global Eculizumab Sales Market Share by Manufacturer in 2018
Table Global Eculizumab Revenue by Manufacturer (2017-2018)
Figure Global Eculizumab Revenue Market Share by Manufacturer in 2017
Figure Global Eculizumab Revenue Market Share by Manufacturer in 2018
Figure Top 3 Eculizumab Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Eculizumab Manufacturer (Revenue) Market Share in 2018
Figure Global Eculizumab Sales and Growth Rate (2014-2019)
Figure Global Eculizumab Revenue and Growth Rate (2014-2019)
Table Global Eculizumab Sales by Regions (2014-2019)
Table Global Eculizumab Sales Market Share by Regions (2014-2019)
Table Global Eculizumab Revenue by Regions (2014-2019)
Figure Global Eculizumab Revenue Market Share by Regions in 2014
Figure Global Eculizumab Revenue Market Share by Regions in 2018
Figure North America Eculizumab Sales and Growth Rate (2014-2019)
Figure Europe Eculizumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Eculizumab Sales and Growth Rate (2014-2019)
Figure South America Eculizumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Eculizumab Sales and Growth Rate (2014-2019)
Figure North America Eculizumab Revenue and Growth Rate (2014-2019)
Table North America Eculizumab Sales by Countries (2014-2019)
Table North America Eculizumab Sales Market Share by Countries (2014-2019)
Figure North America Eculizumab Sales Market Share by Countries in 2014
Figure North America Eculizumab Sales Market Share by Countries in 2018
Table North America Eculizumab Revenue by Countries (2014-2019)
Table North America Eculizumab Revenue Market Share by Countries (2014-2019)
Figure North America Eculizumab Revenue Market Share by Countries in 2014
Figure North America Eculizumab Revenue Market Share by Countries in 2018
Figure United States Eculizumab Sales and Growth Rate (2014-2019)
Figure Canada Eculizumab Sales and Growth Rate (2014-2019)
Figure Mexico Eculizumab Sales and Growth Rate (2014-2019)
Figure Europe Eculizumab Revenue and Growth Rate (2014-2019)
Table Europe Eculizumab Sales by Countries (2014-2019)
Table Europe Eculizumab Sales Market Share by Countries (2014-2019)
Table Europe Eculizumab Revenue by Countries (2014-2019)
Figure Europe Eculizumab Revenue Market Share by Countries in 2017
Figure Europe Eculizumab Revenue Market Share by Countries in 2018
Figure Germany Eculizumab Sales and Growth Rate (2014-2019)
Figure UK Eculizumab Sales and Growth Rate (2014-2019)
Figure France Eculizumab Sales and Growth Rate (2014-2019)
Figure Russia Eculizumab Sales and Growth Rate (2014-2019)
Figure Italy Eculizumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Eculizumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Eculizumab Sales by Countries (2014-2019)
Table Asia-Pacific Eculizumab Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Eculizumab Sales Market Share by Countries 2018
Table Asia-Pacific Eculizumab Revenue by Countries (2014-2019)
Figure Asia-Pacific Eculizumab Revenue Market Share by Countries 2018
Figure China Eculizumab Sales and Growth Rate (2014-2019)
Figure Japan Eculizumab Sales and Growth Rate (2014-2019)
Figure Korea Eculizumab Sales and Growth Rate (2014-2019)
Figure India Eculizumab Sales and Growth Rate (2014-2019)
Figure Southeast Asia Eculizumab Sales and Growth Rate (2014-2019)
Figure South America Eculizumab Revenue and Growth Rate (2014-2019)
Table South America Eculizumab Sales by Countries (2014-2019)
Table South America Eculizumab Sales Market Share by Countries (2014-2019)
Figure South America Eculizumab Sales Market Share by Countries in 2018
Table South America Eculizumab Revenue by Countries (2014-2019)
Table South America Eculizumab Revenue Market Share by Countries (2014-2019)
Figure South America Eculizumab Revenue Market Share by Countries in 2018
Figure Brazil Eculizumab Sales and Growth Rate (2014-2019)
Figure Argentina Eculizumab Sales and Growth Rate (2014-2019)
Figure Colombia Eculizumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Eculizumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Eculizumab Sales by Countries (2014-2019)
Table Middle East and Africa Eculizumab Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Eculizumab Sales Market Share by Countries in 2018
Table Middle East and Africa Eculizumab Revenue by Countries (2014-2019)
Table Middle East and Africa Eculizumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Eculizumab Revenue Market Share by Countries in 2014
Figure Middle East and Africa Eculizumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Eculizumab Sales and Growth Rate (2014-2019)
Figure UAE Eculizumab Sales and Growth Rate (2014-2019)
Figure Egypt Eculizumab Sales and Growth Rate (2014-2019)
Figure Nigeria Eculizumab Sales and Growth Rate (2014-2019)
Figure South Africa Eculizumab Sales and Growth Rate (2014-2019)
Table Global Eculizumab Sales by Type (2014-2019)
Table Global Eculizumab Sales Share by Type (2014-2019)
Table Global Eculizumab Revenue by Type (2014-2019)
Table Global Eculizumab Revenue Share by Type (2014-2019)
Figure Global Plasma Exchange Sales Growth (2014-2019)
Figure Global Plasma Exchange Price (2014-2019)
Figure Global Plasma Infusion Sales Growth (2014-2019)
Figure Global Plasma Infusion Price (2014-2019)
Table Global Eculizumab Sales by Application (2014-2019)
Table Global Eculizumab Sales Share by Application (2014-2019)
Figure Global aHUS Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Eculizumab Sales, Revenue and Growth Rate (2019-2024)
Table Global Eculizumab Sales Forecast by Regions (2019-2024)
Table Global Eculizumab Market Share Forecast by Regions (2019-2024)
Figure North America Sales Eculizumab Market Forecast (2019-2024)
Figure Europe Sales Eculizumab Market Forecast (2019-2024)
Figure Asia-Pacific Sales Eculizumab Market Forecast (2019-2024)
Figure South America Sales Eculizumab Market Forecast (2019-2024)
Figure Middle East and Africa Sales Eculizumab Market Forecast (2019-2024)
Table Global Eculizumab Sales Forecast by Type (2019-2024)
Table Global Eculizumab Market Share Forecast by Type (2019-2024)
Table Global Eculizumab Sales Forecast by Application (2019-2024)
Table Global Eculizumab Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のプラズマ画分市場：市場規模・現状・予測 Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation.Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the …- 世界の血漿タンパク質システム市場：市場規模・現状・予測 Plasma protein system is a unique and biologic pathway that are either injected or infused to treat a life-threatening chronic and generic disease including pulmonary disorder, neurologic disorder, bleeding disorder, immune deficiencies, liver cirrhosis, trauma and others.In 2018, the global Plasma …
- 世界のプラズマエッチング装置市場2019 The global Plasma Etcher market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasma Etcher market status and forecast, categorizes the global Plasma Etcher market size (value & volume) by key pl…
- 世界のプラズマ成分分離装置市場：市場規模・現状・予測 Plasma are generally used to increase blood volume or it can be separated into individual plasma proteins such as fibrinogen, factor VIII, anti-thrombin III and factor IX.Improving healthcare infrastructure is expected to boost the growth of the plasma component separator market. In 2018, the global…
- 世界の血漿プロテアーゼC1阻害剤治療市場2019 The global Plasma Protease C1-inhibitor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Plasma Protease C1-inhibitor Treatment market status and forecast, categorizes the global Pl…